Compile Data Set for Download or QSAR
maximum 50k data
Found 959 with Last Name = 'caroff' and Initial = 'e'
TargetC-X-C chemokine receptor type 3/Guanine nucleotide-binding protein subunit alpha-15(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM208708(US9266876, 175)
Affinity DataIC50:  0.100nMpH: 7.4 T: 2°CAssay Description:The bioactivity of compounds is tested in a fluorometric imaging plate reader (FLIPR: Molecular Devices) using engineered CHO-K1 cells expressing the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3/Guanine nucleotide-binding protein subunit alpha-15(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM208709(US9266876, 176)
Affinity DataIC50:  0.100nMpH: 7.4 T: 2°CAssay Description:The bioactivity of compounds is tested in a fluorometric imaging plate reader (FLIPR: Molecular Devices) using engineered CHO-K1 cells expressing the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3/Guanine nucleotide-binding protein subunit alpha-15(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM208772(US9266876, 239)
Affinity DataIC50:  0.100nMpH: 7.4 T: 2°CAssay Description:The bioactivity of compounds is tested in a fluorometric imaging plate reader (FLIPR: Molecular Devices) using engineered CHO-K1 cells expressing the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3/Guanine nucleotide-binding protein subunit alpha-15(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM208556(US9266876, 23)
Affinity DataIC50:  0.200nMpH: 7.4 T: 2°CAssay Description:The bioactivity of compounds is tested in a fluorometric imaging plate reader (FLIPR: Molecular Devices) using engineered CHO-K1 cells expressing the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3/Guanine nucleotide-binding protein subunit alpha-15(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM208674(US9266876, 141)
Affinity DataIC50:  0.200nMpH: 7.4 T: 2°CAssay Description:The bioactivity of compounds is tested in a fluorometric imaging plate reader (FLIPR: Molecular Devices) using engineered CHO-K1 cells expressing the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3/Guanine nucleotide-binding protein subunit alpha-15(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM208707(US9266876, 174)
Affinity DataIC50:  0.200nMpH: 7.4 T: 2°CAssay Description:The bioactivity of compounds is tested in a fluorometric imaging plate reader (FLIPR: Molecular Devices) using engineered CHO-K1 cells expressing the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3/Guanine nucleotide-binding protein subunit alpha-15(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM208702(US9266876, 169)
Affinity DataIC50:  0.300nMpH: 7.4 T: 2°CAssay Description:The bioactivity of compounds is tested in a fluorometric imaging plate reader (FLIPR: Molecular Devices) using engineered CHO-K1 cells expressing the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3/Guanine nucleotide-binding protein subunit alpha-15(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM208720(US9266876, 187)
Affinity DataIC50:  0.300nMpH: 7.4 T: 2°CAssay Description:The bioactivity of compounds is tested in a fluorometric imaging plate reader (FLIPR: Molecular Devices) using engineered CHO-K1 cells expressing the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Idorsia Pharmaceuticals

US Patent
LigandPNGBDBM610449(2-(3-Cyclopropyl-pyrazol-1-yl)-1-{(S)-2-hydroxymet...)
Affinity DataIC50:  0.380nMAssay Description:The bioactivity of compounds is tested in a fluorometric imaging plate reader (FLIPR: Molecular Devices) using engineered CHO-K1 cells expressing the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3/Guanine nucleotide-binding protein subunit alpha-15(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM208624(US9266876, 91)
Affinity DataIC50:  0.400nMpH: 7.4 T: 2°CAssay Description:The bioactivity of compounds is tested in a fluorometric imaging plate reader (FLIPR: Molecular Devices) using engineered CHO-K1 cells expressing the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3/Guanine nucleotide-binding protein subunit alpha-15(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM208732(US9266876, 199)
Affinity DataIC50:  0.400nMpH: 7.4 T: 2°CAssay Description:The bioactivity of compounds is tested in a fluorometric imaging plate reader (FLIPR: Molecular Devices) using engineered CHO-K1 cells expressing the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Idorsia Pharmaceuticals

US Patent
LigandPNGBDBM610445(2-(3-Cyclopropyl-pyrazol-1-yl)-1-{(R)-2-(2-hydroxy...)
Affinity DataIC50:  0.450nMAssay Description:The bioactivity of compounds is tested in a fluorometric imaging plate reader (FLIPR: Molecular Devices) using engineered CHO-K1 cells expressing the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3/Guanine nucleotide-binding protein subunit alpha-15(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM208627(US9266876, 94)
Affinity DataIC50:  0.5nMpH: 7.4 T: 2°CAssay Description:The bioactivity of compounds is tested in a fluorometric imaging plate reader (FLIPR: Molecular Devices) using engineered CHO-K1 cells expressing the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3/Guanine nucleotide-binding protein subunit alpha-15(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM208706(US9266876, 173)
Affinity DataIC50:  0.5nMpH: 7.4 T: 2°CAssay Description:The bioactivity of compounds is tested in a fluorometric imaging plate reader (FLIPR: Molecular Devices) using engineered CHO-K1 cells expressing the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3/Guanine nucleotide-binding protein subunit alpha-15(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM208629(US9266876, 96)
Affinity DataIC50:  0.5nMpH: 7.4 T: 2°CAssay Description:The bioactivity of compounds is tested in a fluorometric imaging plate reader (FLIPR: Molecular Devices) using engineered CHO-K1 cells expressing the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Idorsia Pharmaceuticals

US Patent
LigandPNGBDBM228190(1-{(R)-4-[4-(2-Cyclopropyl-pyrimidin-5-yl)-2-trifl...)
Affinity DataIC50:  0.700nMpH: 7.4Assay Description:The bioactivity of compounds is tested in a fluorometric imaging plate reader (FLIPR: Molecular Devices) using engineered CHO-K1 cells expressing the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Idorsia Pharmaceuticals

US Patent
LigandPNGBDBM610418(2-(5-Fluoro-indol-1-yl)-1-{(R)-2-hydroxymethyl-4-[...)
Affinity DataIC50:  0.700nMAssay Description:The bioactivity of compounds is tested in a fluorometric imaging plate reader (FLIPR: Molecular Devices) using engineered CHO-K1 cells expressing the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Idorsia Pharmaceuticals

US Patent
LigandPNGBDBM389791(2-Imidazo[4,5-b]pyridin-3-yl-1-{(R)-2-methyl-4-[2-...)
Affinity DataIC50:  0.850nMAssay Description:The bioactivity of compounds is tested in a fluorometric imaging plate reader (FLIPR: Molecular Devices) using engineered CHO-K1 cells expressing the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Idorsia Pharmaceuticals

US Patent
LigandPNGBDBM228186(2-[3-(1-Hydroxy-ethyl)-[1,2,4]triazol-1-yl]-1-{(R)...)
Affinity DataIC50:  0.900nMpH: 7.4Assay Description:The bioactivity of compounds is tested in a fluorometric imaging plate reader (FLIPR: Molecular Devices) using engineered CHO-K1 cells expressing the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Idorsia Pharmaceuticals

US Patent
LigandPNGBDBM389773(US9951063, 92)
Affinity DataIC50:  0.970nMAssay Description:The bioactivity of compounds is tested in a fluorometric imaging plate reader (FLIPR: Molecular Devices) using engineered CHO-K1 cells expressing the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3/Guanine nucleotide-binding protein subunit alpha-15(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM208699(US9266876, 166)
Affinity DataIC50:  1nMpH: 7.4 T: 2°CAssay Description:The bioactivity of compounds is tested in a fluorometric imaging plate reader (FLIPR: Molecular Devices) using engineered CHO-K1 cells expressing the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3/Guanine nucleotide-binding protein subunit alpha-15(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM208700(US9266876, 167)
Affinity DataIC50:  1nMpH: 7.4 T: 2°CAssay Description:The bioactivity of compounds is tested in a fluorometric imaging plate reader (FLIPR: Molecular Devices) using engineered CHO-K1 cells expressing the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3/Guanine nucleotide-binding protein subunit alpha-15(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM208551(US9266876, 18)
Affinity DataIC50:  1nMpH: 7.4 T: 2°CAssay Description:The bioactivity of compounds is tested in a fluorometric imaging plate reader (FLIPR: Molecular Devices) using engineered CHO-K1 cells expressing the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3/Guanine nucleotide-binding protein subunit alpha-15(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM208555(US9266876, 22)
Affinity DataIC50:  1nMpH: 7.4 T: 2°CAssay Description:The bioactivity of compounds is tested in a fluorometric imaging plate reader (FLIPR: Molecular Devices) using engineered CHO-K1 cells expressing the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3/Guanine nucleotide-binding protein subunit alpha-15(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM208557(US9266876, 24)
Affinity DataIC50:  1nMpH: 7.4 T: 2°CAssay Description:The bioactivity of compounds is tested in a fluorometric imaging plate reader (FLIPR: Molecular Devices) using engineered CHO-K1 cells expressing the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3/Guanine nucleotide-binding protein subunit alpha-15(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM208559(US9266876, 26)
Affinity DataIC50:  1nMpH: 7.4 T: 2°CAssay Description:The bioactivity of compounds is tested in a fluorometric imaging plate reader (FLIPR: Molecular Devices) using engineered CHO-K1 cells expressing the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3/Guanine nucleotide-binding protein subunit alpha-15(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM208561(US9266876, 28)
Affinity DataIC50:  1nMpH: 7.4 T: 2°CAssay Description:The bioactivity of compounds is tested in a fluorometric imaging plate reader (FLIPR: Molecular Devices) using engineered CHO-K1 cells expressing the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3/Guanine nucleotide-binding protein subunit alpha-15(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM208584(US9266876, 51)
Affinity DataIC50:  1nMpH: 7.4 T: 2°CAssay Description:The bioactivity of compounds is tested in a fluorometric imaging plate reader (FLIPR: Molecular Devices) using engineered CHO-K1 cells expressing the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3/Guanine nucleotide-binding protein subunit alpha-15(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM208605(US9266876, 72)
Affinity DataIC50:  1nMpH: 7.4 T: 2°CAssay Description:The bioactivity of compounds is tested in a fluorometric imaging plate reader (FLIPR: Molecular Devices) using engineered CHO-K1 cells expressing the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3/Guanine nucleotide-binding protein subunit alpha-15(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM208613(US9266876, 80)
Affinity DataIC50:  1nMpH: 7.4 T: 2°CAssay Description:The bioactivity of compounds is tested in a fluorometric imaging plate reader (FLIPR: Molecular Devices) using engineered CHO-K1 cells expressing the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3/Guanine nucleotide-binding protein subunit alpha-15(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM208616(US9266876, 83)
Affinity DataIC50:  1nMpH: 7.4 T: 2°CAssay Description:The bioactivity of compounds is tested in a fluorometric imaging plate reader (FLIPR: Molecular Devices) using engineered CHO-K1 cells expressing the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3/Guanine nucleotide-binding protein subunit alpha-15(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM208617(US9266876, 84)
Affinity DataIC50:  1nMpH: 7.4 T: 2°CAssay Description:The bioactivity of compounds is tested in a fluorometric imaging plate reader (FLIPR: Molecular Devices) using engineered CHO-K1 cells expressing the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Idorsia Pharmaceuticals

US Patent
LigandPNGBDBM610443(1-{(R)-2-(2-Hydroxy-ethyl)-4-[2-trifluoromethyl-4-...)
Affinity DataIC50:  1nMAssay Description:The bioactivity of compounds is tested in a fluorometric imaging plate reader (FLIPR: Molecular Devices) using engineered CHO-K1 cells expressing the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Idorsia Pharmaceuticals

US Patent
LigandPNGBDBM610446(1-{(S)-2-Hydroxymethyl-4-[2-trifluoromethyl-4-(2-t...)
Affinity DataIC50:  1nMAssay Description:The bioactivity of compounds is tested in a fluorometric imaging plate reader (FLIPR: Molecular Devices) using engineered CHO-K1 cells expressing the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Idorsia Pharmaceuticals

US Patent
LigandPNGBDBM228176(2-(3-tert-Butyl-[1,2,4]triazol-1-yl)-1-{(R)-4-[4-(...)
Affinity DataIC50:  1nMpH: 7.4Assay Description:The bioactivity of compounds is tested in a fluorometric imaging plate reader (FLIPR: Molecular Devices) using engineered CHO-K1 cells expressing the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3/Guanine nucleotide-binding protein subunit alpha-15(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM208704(US9266876, 171)
Affinity DataIC50:  1nMpH: 7.4 T: 2°CAssay Description:The bioactivity of compounds is tested in a fluorometric imaging plate reader (FLIPR: Molecular Devices) using engineered CHO-K1 cells expressing the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3/Guanine nucleotide-binding protein subunit alpha-15(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM208705(US9266876, 172)
Affinity DataIC50:  1nMpH: 7.4 T: 2°CAssay Description:The bioactivity of compounds is tested in a fluorometric imaging plate reader (FLIPR: Molecular Devices) using engineered CHO-K1 cells expressing the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3/Guanine nucleotide-binding protein subunit alpha-15(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM208723(US9266876, 190)
Affinity DataIC50:  1nMpH: 7.4 T: 2°CAssay Description:The bioactivity of compounds is tested in a fluorometric imaging plate reader (FLIPR: Molecular Devices) using engineered CHO-K1 cells expressing the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3/Guanine nucleotide-binding protein subunit alpha-15(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM208724(US9266876, 191)
Affinity DataIC50:  1nMpH: 7.4 T: 2°CAssay Description:The bioactivity of compounds is tested in a fluorometric imaging plate reader (FLIPR: Molecular Devices) using engineered CHO-K1 cells expressing the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3/Guanine nucleotide-binding protein subunit alpha-15(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM208725(US9266876, 192)
Affinity DataIC50:  1nMpH: 7.4 T: 2°CAssay Description:The bioactivity of compounds is tested in a fluorometric imaging plate reader (FLIPR: Molecular Devices) using engineered CHO-K1 cells expressing the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3/Guanine nucleotide-binding protein subunit alpha-15(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM208726(US9266876, 193)
Affinity DataIC50:  1nMpH: 7.4 T: 2°CAssay Description:The bioactivity of compounds is tested in a fluorometric imaging plate reader (FLIPR: Molecular Devices) using engineered CHO-K1 cells expressing the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3/Guanine nucleotide-binding protein subunit alpha-15(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM208735(US9266876, 202)
Affinity DataIC50:  1nMpH: 7.4 T: 2°CAssay Description:The bioactivity of compounds is tested in a fluorometric imaging plate reader (FLIPR: Molecular Devices) using engineered CHO-K1 cells expressing the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3/Guanine nucleotide-binding protein subunit alpha-15(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM208740(US9266876, 207)
Affinity DataIC50:  1nMpH: 7.4 T: 2°CAssay Description:The bioactivity of compounds is tested in a fluorometric imaging plate reader (FLIPR: Molecular Devices) using engineered CHO-K1 cells expressing the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3/Guanine nucleotide-binding protein subunit alpha-15(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM208741(US9266876, 208)
Affinity DataIC50:  1nMpH: 7.4 T: 2°CAssay Description:The bioactivity of compounds is tested in a fluorometric imaging plate reader (FLIPR: Molecular Devices) using engineered CHO-K1 cells expressing the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3/Guanine nucleotide-binding protein subunit alpha-15(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM208743(US9266876, 210)
Affinity DataIC50:  1nMpH: 7.4 T: 2°CAssay Description:The bioactivity of compounds is tested in a fluorometric imaging plate reader (FLIPR: Molecular Devices) using engineered CHO-K1 cells expressing the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3/Guanine nucleotide-binding protein subunit alpha-15(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM208744(US9266876, 211)
Affinity DataIC50:  1nMpH: 7.4 T: 2°CAssay Description:The bioactivity of compounds is tested in a fluorometric imaging plate reader (FLIPR: Molecular Devices) using engineered CHO-K1 cells expressing the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3/Guanine nucleotide-binding protein subunit alpha-15(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM208746(US9266876, 213)
Affinity DataIC50:  1nMpH: 7.4 T: 2°CAssay Description:The bioactivity of compounds is tested in a fluorometric imaging plate reader (FLIPR: Molecular Devices) using engineered CHO-K1 cells expressing the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3/Guanine nucleotide-binding protein subunit alpha-15(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM208759(US9266876, 226)
Affinity DataIC50:  1nMpH: 7.4 T: 2°CAssay Description:The bioactivity of compounds is tested in a fluorometric imaging plate reader (FLIPR: Molecular Devices) using engineered CHO-K1 cells expressing the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3/Guanine nucleotide-binding protein subunit alpha-15(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM208762(US9266876, 229)
Affinity DataIC50:  1nMpH: 7.4 T: 2°CAssay Description:The bioactivity of compounds is tested in a fluorometric imaging plate reader (FLIPR: Molecular Devices) using engineered CHO-K1 cells expressing the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3/Guanine nucleotide-binding protein subunit alpha-15(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM208763(US9266876, 230)
Affinity DataIC50:  1nMpH: 7.4 T: 2°CAssay Description:The bioactivity of compounds is tested in a fluorometric imaging plate reader (FLIPR: Molecular Devices) using engineered CHO-K1 cells expressing the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 959 total ) | Next | Last >>
Jump to: